Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Forman, R.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Forman, R.G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 14, No. 11, 2681-2688, November 1999
© 1999 European Society of Human Reproduction and Embryology


Debate continued

Severe OHSS—an acceptable price?

R.G. Forman

Centre for Reproductive Medicine, 94 Harley Street, London W1N 1AF, UK

The first 10% of the full text of this article appears below.

Burgeoning literature over the past decade has well documented the complication of severe ovarian hyperstimulation syndrome (OHSS). All clinicians involved in the management of infertile women should be expected to know the presentation and management of this serious condition. The contribution by Abramov et al. is useful as it presents a large retrospective analysis of virtually an entire country's worth of data from tertiary referral centres over a 10 year period (Abramov et al., 1999Go). However, I would disagree with several of the conclusions drawn by the authors and I would regard their data as being reassuring rather than a cause for concern. They describe an `epidemic' of OHSS. An epidemic would be defined as a . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
P. Devroey, M. Aboulghar, J. Garcia-Velasco, G. Griesinger, P. Humaidan, E. Kolibianakis, W. Ledger, C. Tomas, and B. C.J.M. Fauser
Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment
Hum. Reprod., April 1, 2009; 24(4): 764 - 774.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
M.F.G. Verberg, M.J.C. Eijkemans, N.S. Macklon, E.M.E.W. Heijnen, E.B. Baart, F.P. Hohmann, B.C.J.M. Fauser, and F.J. Broekmans
The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis
Hum. Reprod. Update, January 1, 2009; 15(1): 5 - 12.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
J. Collins
Mild stimulation for in vitro fertilization: making progress downward
Hum. Reprod. Update, January 1, 2009; 15(1): 1 - 3.
[Full Text] [PDF]


Home page
Hum ReprodHome page
B. C. Heng
Stringent regulation of oocyte donation in China
Hum. Reprod., January 1, 2009; 24(1): 14 - 16.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
M.F.G. Verberg, N.S. Macklon, G. Nargund, R. Frydman, P. Devroey, F.J. Broekmans, and B.C.J.M. Fauser
Mild ovarian stimulation for IVF
Hum. Reprod. Update, January 1, 2009; 15(1): 13 - 29.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
W. Verpoest, B.C. Fauser, E. Papanikolaou, C. Staessen, L. Van Landuyt, P. Donoso, H. Tournaye, I. Liebaers, and P. Devroey
Chromosomal aneuploidy in embryos conceived with unstimulated cycle IVF
Hum. Reprod., October 1, 2008; 23(10): 2369 - 2371.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M.F.G. Verberg, M.J.C. Eijkemans, E.M.E.W. Heijnen, F.J. Broekmans, C. de Klerk, B.C.J.M. Fauser, and N.S. Macklon
Why do couples drop-out from IVF treatment? A prospective cohort study
Hum. Reprod., September 1, 2008; 23(9): 2050 - 2055.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. Polinder, E.M.E.W. Heijnen, N.S. Macklon, J.D.F. Habbema, B.J.C.M. Fauser, and M.J.C. Eijkemans
Cost-effectiveness of a mild compared with a standard strategy for IVF: a randomized comparison using cumulative term live birth as the primary endpoint
Hum. Reprod., February 1, 2008; 23(2): 316 - 323.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
The ESHRE Capri Workshop Group
Intracytoplasmic sperm injection (ICSI) in 2006: Evidence and Evolution
Hum. Reprod. Update, November 1, 2007; 13(6): 515 - 526.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
G. Nargund, B.C.J.M. Fauser, N.S. Macklon, W. Ombelet, K. Nygren, R. Frydman, and for the Rotterdam ISMAAR Consensus Group on Termin
The ISMAAR proposal on terminology for ovarian stimulation for IVF
Hum. Reprod., November 1, 2007; 22(11): 2801 - 2804.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C. de Klerk, N.S. Macklon, E.M.E.W. Heijnen, M.J.C. Eijkemans, B.C.J.M. Fauser, J. Passchier, and J.A.M. Hunfeld
The psychological impact of IVF failure after two or more cycles of IVF with a mild versus standard treatment strategy
Hum. Reprod., September 1, 2007; 22(9): 2554 - 2558.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
G. Pennings and W. Ombelet
Coming soon to your clinic: patient-friendly ART
Hum. Reprod., August 1, 2007; 22(8): 2075 - 2079.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M.F.G. Verberg, M.J.C. Eijkemans, N.S. Macklon, E.M.E.W. Heijnen, B.C.J.M. Fauser, and F.J. Broekmans
Predictors of low response to mild ovarian stimulation initiated on cycle day 5 for IVF
Hum. Reprod., July 1, 2007; 22(7): 1919 - 1924.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E. B. Baart, E. Martini, M. J. Eijkemans, D. Van Opstal, N. G.M. Beckers, A. Verhoeff, N. S. Macklon, and B. C.J.M. Fauser
Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial
Hum. Reprod., April 1, 2007; 22(4): 980 - 988.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
N. S. Macklon, R. L. Stouffer, L. C. Giudice, and B. C. J. M. Fauser
The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization
Endocr. Rev., April 1, 2006; 27(2): 170 - 207.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C. de Klerk, E.M.E.W. Heijnen, N.S. Macklon, H.J. Duivenvoorden, B.C.J.M. Fauser, J. Passchier, and J.A.M. Hunfeld
The psychological impact of mild ovarian stimulation combined with single embryo transfer compared with conventional IVF
Hum. Reprod., March 1, 2006; 21(3): 721 - 727.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M.J.C. Eijkemans, E.M.E.W. Heijnen, C. de Klerk, J.D.F. Habbema, and B.C.J.M. Fauser
Comparison of different treatment strategies in IVF with cumulative live birth over a given period of time as the primary end-point: methodological considerations on a randomized controlled non-inferiority trial
Hum. Reprod., February 1, 2006; 21(2): 344 - 351.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
G. B. Inge, P. R. Brinsden, and K. T. Elder
Oocyte number per live birth in IVF: were Steptoe and Edwards less wasteful?
Hum. Reprod., March 1, 2005; 20(3): 588 - 592.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E.M.E.W. Heijnen, N.S. Macklon, and B.C.J.M. Fauser
What is the most relevant standard of success in assisted reproduction?: The next step to improving outcomes of IVF: consider the whole treatment
Hum. Reprod., September 1, 2004; 19(9): 1936 - 1938.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E. J. de Boer, I. Den Tonkelaar, C. W. Burger, C.W.N. Looman, F. E. van Leeuwen, E. R. te Velde, and on behalf of the OMEGA project group
The number of retrieved oocytes does not decrease during consecutive gonadotrophin-stimulated IVF cycles
Hum. Reprod., April 1, 2004; 19(4): 899 - 904.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E.B. Baart, D. Van Opstal, F.J. Los, B.C.J.M. Fauser, and E. Martini
Fluorescence in situ hybridization analysis of two blastomeres from day 3 frozen-thawed embryos followed by analysis of the remaining embryo on day 5
Hum. Reprod., March 1, 2004; 19(3): 685 - 693.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
H. Klip, F. E. van Leeuwen, R. Schats, C.W. Burger, and for the OMEGA project group
Risk of benign gynaecological diseases and hormonal disorders according to responsiveness to ovarian stimulation in IVF: a follow-up study of 8714 women
Hum. Reprod., September 1, 2003; 18(9): 1951 - 1958.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
A. T. Davenport, C. J. Lees, H. L. Green, and K. A. Grant
Long-Acting Depot Formulation of Luprolide Acetate as a Method of Hypothalamic Down Regulation for Controlled Ovarian Hyperstimulation and Oocyte Production in Macaca fascicularis
Biol Reprod, June 1, 2003; 68(6): 2261 - 2266.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. P. Hohmann, N. S. Macklon, and B. C. J. M. Fauser
A Randomized Comparison of Two Ovarian Stimulation Protocols with Gonadotropin-Releasing Hormone (GnRH) Antagonist Cotreatment for in Vitro Fertilization Commencing Recombinant Follicle-Stimulating Hormone on Cycle Day 2 or 5 with the Standard Long GnRH Agonist Protocol
J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 166 - 173.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
N.S. Macklon, M.H.E.C. Pieters, M.A. Hassan, P.H.M. Jeucken, M.J.C. Eijkemans, and B.C.J.M. Fauser
A prospective randomized comparison of sequential versus monoculture systems for in-vitro human blastocyst development
Hum. Reprod., October 1, 2002; 17(10): 2700 - 2705.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. D. Neill
Minireview: GnRH and GnRH Receptor Genes in the Human Genome
Endocrinology, March 1, 2002; 143(3): 737 - 743.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. C. Fauser, D. de Jong, F. Olivennes, H. Wramsby, C. Tay, J. Itskovitz-Eldor, and H. G. van Hooren
Endocrine Profiles after Triggering of Final Oocyte Maturation with GnRH Agonist after Cotreatment with the GnRH Antagonist Ganirelix during Ovarian Hyperstimulation for in Vitro Fertilization
J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 709 - 715.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. A. Garcia-Velasco, V. Isaza, C. Vidal, A. Landazabal, J. Remohi, C. Simon, and A. Pellicer
Human ovarian steroid secretion in vivo: effects of GnRH agonist versus antagonist (cetrorelix)
Hum. Reprod., December 1, 2001; 16(12): 2533 - 2539.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C. Caligara, J. Navarro, G. Vargas, C. Simon, A. Pellicer, and J. Remohi
The effect of repeated controlled ovarian stimulation in donors
Hum. Reprod., November 1, 2001; 16(11): 2320 - 2323.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
D. T. Baird
Is there a place for different isoforms of FSH in clinical medicine?: IV. The clinician's point of view
Hum. Reprod., July 1, 2001; 16(7): 1316 - 1318.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
H. J. Out, I. David, R. Ron-El, S. Friedler, E. Shalev, J. Geslevich, J. Dor, A. Shulman, Z. Ben-Rafael, B. Fisch, et al.
A randomized, double-blind clinical trial using fixed daily doses of 100 or 200 IU of recombinant FSH in ICSI cycles
Hum. Reprod., June 1, 2001; 16(6): 1104 - 1109.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
F.P. Hohmann, J.S.E. Laven, F.H. de Jong, M.J.C. Eijkemans, and B.C.J.M. Fauser
Low-dose exogenous FSH initiated during the early, mid or late follicular phase can induce multiple dominant follicle development
Hum. Reprod., May 1, 2001; 16(5): 846 - 854.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
D.K. Lobb and E.V. Younglai
Granulosa-luteal cell function in vitro and ovarian stimulation protocols
Hum. Reprod., January 1, 2001; 16(1): 195 - 196.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. P. Mayorga, J. Gromoll, H. M. Behre, C. Gassner, E. Nieschlag, and M. Simoni
Ovarian Response to Follicle-Stimulating Hormone (FSH) Stimulation Depends on the FSH Receptor Genotype
J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3365 - 3369.
[Abstract] [Full Text]


Home page
Hum ReprodHome page
E. R. Hernandez
Embryo implantation and GnRH antagonists: Embryo implantation: the Rubicon for GnRH antagonists
Hum. Reprod., June 1, 2000; 15(6): 1211 - 1216.
[Abstract] [Full Text] [PDF]